Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 23071237

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2013 Jan 20
First author
van den Bent MJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2012 Dec;9(12):670. doi: 10.1038/nrclinonc.2012.198.
    note
    Source null
    related pmid
    23149899
    relationship
    Comment in

Authors and identifiers

  1. name
    van den Bent MJ
    type
    Author
  2. name
    Brandes AA
    type
    Author
  3. name
    Taphoorn MJ
    type
    Author
  4. name
    Kros JM
    type
    Author
  5. name
    Kouwenhoven MC
    type
    Author
  6. name
    Delattre JY
    type
    Author
  7. name
    Bernsen HJ
    type
    Author
  8. name
    Frenay M
    type
    Author
  9. name
    Tijssen CC
    type
    Author
  10. name
    Grisold W
    type
    Author
  11. name
    Sipos L
    type
    Author
  12. name
    Enting RH
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    van den Bent MJ
    type
    Author
  2. name
    Brandes AA
    type
    Author
  3. name
    Taphoorn MJ
    type
    Author
  4. name
    Kros JM
    type
    Author
  5. name
    Kouwenhoven MC
    type
    Author
  6. name
    Delattre JY
    type
    Author
  7. name
    Bernsen HJ
    type
    Author
  8. name
    Frenay M
    type
    Author
  9. name
    Tijssen CC
    type
    Author
  10. name
    Grisold W
    type
    Author
  11. name
    Sipos L
    type
    Author
  12. name
    Enting RH
    type
    Author
bibliography ids
  1. nci-bib-5d19275eefa15d2a8f09c987
book metadata
content sha256
a3b5d513f4e806bafea64cdd0b6243d67ab46d31e6c32e7bcaf9b9549ba5f647
document type
citation
dois
  1. 10.1200/JCO.2012.43.2229
electronic publication date
display
2012 Oct 15
precision
day
year
2012
evidence scope
bibliographic_metadata_only
id
pubmed:23071237
immutable id
pubmed:23071237@a3b5d513f4e806bafea64cdd0b6243d67ab46d31e6c32e7bcaf9b9549ba5f647
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
3
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
344-50
volume
31
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2012 Dec;9(12):670. doi: 10.1038/nrclinonc.2012.198.
    note
    Source null
    related pmid
    23149899
    relationship
    Comment in
outcomes validated
false
pmid
23071237
provenance
batch id
99e85dbb34a1a3011c9a
provider
NCBI PubMed ESummary
record sha256
d03a8c1057d7568fc70fdf422d538e32b7cd54a9016db2539898006dde8e1bfd
response sha256
1f4a46dcee9da36f8f58fe356dce3f44a1b3004f404e9fb0184f4e08aed4acf2
retrieved at
2026-09-09T23:46:52.860383+00:00
publication date
display
2013 Jan 20
precision
day
year
2013
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/23071237/
title
Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

Preserved source evidence · Not medical advice